ZA961349B - Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications - Google Patents

Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications

Info

Publication number: ZA961349B
Authority: ZA; South Africa
Prior art keywords: sequences; expression; amplifying; compositions; vectors
Prior art date: 1995-02-20

Application number

ZA961349A

Other languages

English (en)

Inventor

Denise Paulin

Zehn Lin Li

Original Assignee

Pasteur Institut

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-20

Filing date

1996-02-20

Publication date

1996-09-05

1996-02-20 Application filed by Pasteur Institut filed Critical Pasteur Institut

1996-09-05 Publication of ZA961349B publication Critical patent/ZA961349B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Plant Pathology (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA961349A 1995-02-20 1996-02-20 Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications ZA961349B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9501937A FR2730735B1 (fr)	1995-02-20	1995-02-20	Sequences amplificatrices, vecteurs portant ces sequences et leurs utilisations dans des compositions pour l'expression de sequences nucleotidiques dans des cellules transfectees, applications therapeutiques et vaccinales

Publications (1)

Publication Number	Publication Date
ZA961349B true ZA961349B (en)	1996-09-05

Family

ID=9476320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA961349A ZA961349B (en)	1995-02-20	1996-02-20	Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications

Country Status (15)

Country	Link
US (2)	US5914395A (xx)
EP (1)	EP0811071B1 (xx)
JP (1)	JPH11500905A (xx)
AT (1)	ATE212060T1 (xx)
AU (1)	AU710697B2 (xx)
CA (1)	CA2211435A1 (xx)
DE (1)	DE69618574T2 (xx)
DK (1)	DK0811071T3 (xx)
ES (1)	ES2168459T3 (xx)
FR (1)	FR2730735B1 (xx)
IL (1)	IL117194A0 (xx)
MX (1)	MX9706290A (xx)
PT (1)	PT811071E (xx)
WO (1)	WO1996026284A1 (xx)
ZA (1)	ZA961349B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU8788998A (en) *	1998-10-02	2000-04-06	Universite Paris 7	Vascular specific regulatory elements contained in the desmin 5' flanking region
EP1648931B1 (en)	2003-07-21	2011-02-09	Transgene S.A.	Multifunctional cytokines
ES2625406T3 (es)	2010-03-25	2017-07-19	Oregon Health & Science University	Glicoproteínas de CMV y vectores recombinantes
RS57397B8 (sr)	2011-06-10	2020-01-31	Univ Oregon Health & Science	Cmv glikoproteini i rekombinantni vektori
CA2789539A1 (en)	2011-09-12	2013-03-12	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en)	2011-10-27	2016-08-02	International Aids Vaccine Initiative	Viral particles derived from an enveloped virus
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
US9657076B2 (en)	2012-10-23	2017-05-23	Emory University	GM-CSF and IL-4 conjugates, compositions, and methods related thereto
US20150065381A1 (en)	2013-09-05	2015-03-05	International Aids Vaccine Initiative	Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en)	2013-10-07	2017-05-31	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
SG11201605906UA (en)	2014-01-21	2016-08-30	Univ Bruxelles	Muscle-specific nucleic acid regulatory elements and methods and use thereof
EP3069730A3 (en)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3723075A1 (de) *	1987-07-11	1989-01-19	Boehringer Mannheim Gmbh	Eukaryotische expressionsvektoren mit multimeren enhancer-subelementen, verfahren zu ihrer herstellung und verwendung
US5503980A (en) *	1992-11-06	1996-04-02	Trustees Of Boston University	Positional sequencing by hybridization

1995
- 1995-02-20 FR FR9501937A patent/FR2730735B1/fr not_active Expired - Fee Related
1996
- 1996-02-16 WO PCT/FR1996/000261 patent/WO1996026284A1/fr active IP Right Grant
- 1996-02-16 AU AU48356/96A patent/AU710697B2/en not_active Ceased
- 1996-02-16 CA CA002211435A patent/CA2211435A1/fr not_active Abandoned
- 1996-02-16 US US08/894,228 patent/US5914395A/en not_active Expired - Fee Related
- 1996-02-16 JP JP8525445A patent/JPH11500905A/ja active Pending
- 1996-02-16 ES ES96904158T patent/ES2168459T3/es not_active Expired - Lifetime
- 1996-02-16 PT PT96904158T patent/PT811071E/pt unknown
- 1996-02-16 AT AT96904158T patent/ATE212060T1/de not_active IP Right Cessation
- 1996-02-16 EP EP96904158A patent/EP0811071B1/fr not_active Expired - Lifetime
- 1996-02-16 MX MX9706290A patent/MX9706290A/es not_active IP Right Cessation
- 1996-02-16 DE DE69618574T patent/DE69618574T2/de not_active Expired - Fee Related
- 1996-02-16 DK DK96904158T patent/DK0811071T3/da active
- 1996-02-20 IL IL11719496A patent/IL117194A0/xx unknown
- 1996-02-20 ZA ZA961349A patent/ZA961349B/xx unknown
1998
- 1998-11-13 US US09/191,521 patent/US6201115B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US5914395A (en)	1999-06-22
MX9706290A (es)	1998-02-28
US6201115B1 (en)	2001-03-13
EP0811071B1 (fr)	2002-01-16
DK0811071T3 (da)	2002-04-29
IL117194A0 (en)	1996-06-18
JPH11500905A (ja)	1999-01-26
DE69618574D1 (de)	2002-02-21
ES2168459T3 (es)	2002-06-16
ATE212060T1 (de)	2002-02-15
EP0811071A1 (fr)	1997-12-10
AU4835696A (en)	1996-09-11
CA2211435A1 (fr)	1996-08-29
AU710697B2 (en)	1999-09-30
WO1996026284A1 (fr)	1996-08-29
FR2730735B1 (fr)	1997-05-09
DE69618574T2 (de)	2002-08-14
FR2730735A1 (fr)	1996-08-23
PT811071E (pt)	2002-07-31

Publication	Publication Date	Title
ZA961349B (en)	1996-09-05	Amplifying sequences vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications
EP1209237A3 (en)	2002-07-31	Synthetic DNA sequence having enhanced insecticidal activity in maize
AU8067698A (en)	1998-12-30	Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
DE69429631D1 (en)	2002-02-14	Conotoxinpeptide
AU6871398A (en)	1998-10-22	Method for enhancing expression of a foreign or endogenous gene product in pla nts
AU2003264419A1 (en)	2004-04-30	Kdr peptides and vaccines containing the same
SG165153A1 (en)	2010-10-28	Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
IL133544A0 (en)	2001-04-30	Lag-3 splice variants, their preparation and use
WO2001036623A3 (en)	2002-02-21	Ecdysone-inducible adeno-associated virus expression vectors
WO2003093417A3 (en)	2004-10-28	Lentiviral vector particles resistant to complement inactivation
CA2327266A1 (en)	1999-11-11	Pesticidal toxins and nucleotide sequences which encode these toxins
AU6724794A (en)	1995-04-03	GRB3-3 gene, its variants and their uses
WO1999028439A3 (fr)	1999-07-22	Erythrovirus et ses applications
FR2685004B1 (xx)	1995-01-06
WO2000012741A3 (fr)	2000-05-04	Systeme d'expression inductible
DE60028217D1 (de)	2006-06-29	Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden
GB9416536D0 (en)	1994-10-12	Orphan receptor
AU782261C (en)	2006-02-23	Novel glycosyltransferase genes
HUP0004857A2 (hu)	2001-04-28	T. variabilisból származó D-aminosav oxidáz promótere
HUP0104598A1 (hu)	2002-03-28	Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek
EP1158052A4 (en)	2002-10-02	BETA-PRIMEVEROSIDASDE GENE